Company: MYSEW
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001213900-25-115502
Chunk: 12

Company: Myseum, Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 12
---
 is a summary of the securities we may offer with this prospectus. Common Stock We currently have authorized 180,000,000 shares of common stock, par value $0.0001 per share. As of November 25, 2025, 4,264,329 shares of common stock were issued and outstanding. We may offer shares of our common stock either alone or underlying other registered securities convertible into or exercisable for our common stock. Holders of our common stock are entitled to such dividends as our board of directors (the “Board of Directors” or “Board”) may declare from time to time out of legally available funds, subject to the preferential rights of the holders of any shares of our preferred stock that are outstanding or that we may issue in the future. Currently, we do not pay any dividends on our common stock. Each holder of our common stock is entitled to one vote per share. In this prospectus, we provide a general description of, among other things, the rights and restrictions that apply to holders of our common stock. Preferred Stock We currently have authorized 20,000,000 shares of preferred stock, par value $0.0001, of which 1 share of our preferred stock has been designated as Series A Preferred Stock and 2,000,000 shares of our preferred stock have been designated as Series B Preferred Stock. No shares of preferred stock are currently outstanding As of November 25, 2025, we have 17,999,999 shares of undesignated preferred stock available for future designation and issuance. The Board of Directors is further authorized, subject to limitations prescribed by law, to fix by resolution or resolutions the designations, powers, preferences and rights, and the qualifications, limitations or restrictions thereof, of any wholly unissued series of preferred stock, including, without limitation, authority to fix by resolution or resolutions the dividend rights, dividend rate, conversion rights, voting rights, rights and terms of redemption (including sinking fund provisions), redemption price or prices, and liquidation preferences of any such series, and the number of shares constituting any such series and the designation thereof, or any of the foregoing. The rights, preferences, privileges, and restrictions granted to or imposed upon any series of preferred stock that we offer and sell under this prospectus and applicable prospectus supplements will be set forth in a certificate of designation relating to the series. We will incorporate by reference into the registration statement of which this prospectus is a part the form of any certificate of designation that describes the